Safety and tolerability of immune checkpoint inhibitors in people with HIV infection and cancer: insights from the national prospective real-world OncoVIHAC ANRS CO24 cohort study. - Assoumou L; Baldé R; Katlama C; Abbar B; Delobel P; Allegre T; Lavole A; Makinson A; Zaegel-Faucher O; Greillier L; Soulie C; Veyri M; et al. (Journal for immunotherapy of cancer, 2024)